Sepsis shortfalls: How current sepsis care and measurement is lacking
In a series of three separate roundtable discussions, Dr. Tidmarsh, MD, PhD, president and CEO of La Jolla Pharmaceutical Company, and his colleague, Steve Chen, MD, La Jolla's vice president of medical affairs, joined a total of 45 hospital C-suite leaders from across the country to assess the challenges and opportunities associated with recommended sepsis protocols.
Becker's Clinical Leadership & Infection Control: https://www.beckershospitalreview.com/quality/sepsis-shortfalls-how-current-sepsis-care-and-measurement-is-lacking.html